𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TCT-69 Safety and clinical performance of the drug eluting Osiro stent in patients with single de novo coronary artery lesions - II (BIOFLOW-II) -A quantitative analysis by IVUS and OCT-

✍ Scribed by Lefevre, Thierry; Windecker, Stephan; Haude, Michael; Stangl, Karl; Sabate, Manel; Goicolea, J.; Slagboom, Ton; Barragan, Paul; Cook, Stéphane; Weissman, Neil; Pawar, Ravindra; Neumann, Franz-Josef

Book ID
122313786
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
70 KB
Volume
62
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Clinical and Economic Analysis
Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)
✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB
ABSORB II randomized controlled trial: A
ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design
✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB